IL108460A - Multi-component inclusion compounds that are easily soluble and contain a base, acid and cyclodextrin type drug - Google Patents
Multi-component inclusion compounds that are easily soluble and contain a base, acid and cyclodextrin type drugInfo
- Publication number
- IL108460A IL108460A IL10846094A IL10846094A IL108460A IL 108460 A IL108460 A IL 108460A IL 10846094 A IL10846094 A IL 10846094A IL 10846094 A IL10846094 A IL 10846094A IL 108460 A IL108460 A IL 108460A
- Authority
- IL
- Israel
- Prior art keywords
- acid
- cyclodextrin
- mmol
- inclusion complexes
- complexes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nanotechnology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI930141A IT1263831B (it) | 1993-01-29 | 1993-01-29 | Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo basico, un acido ed una ciclodestrina |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL108460A0 IL108460A0 (en) | 1994-04-12 |
| IL108460A true IL108460A (en) | 1999-01-26 |
Family
ID=11364792
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL10846094A IL108460A (en) | 1993-01-29 | 1994-01-27 | Multi-component inclusion compounds that are easily soluble and contain a base, acid and cyclodextrin type drug |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5855916A (pt) |
| EP (1) | EP0681481B1 (pt) |
| JP (1) | JPH08508711A (pt) |
| KR (1) | KR960700074A (pt) |
| AT (1) | ATE228013T1 (pt) |
| AU (1) | AU691115B2 (pt) |
| BR (1) | BR9406779A (pt) |
| CA (1) | CA2154874A1 (pt) |
| CZ (1) | CZ284606B6 (pt) |
| DE (1) | DE69431747D1 (pt) |
| FI (1) | FI953590A (pt) |
| HU (1) | HU218796B (pt) |
| IL (1) | IL108460A (pt) |
| IT (1) | IT1263831B (pt) |
| NO (1) | NO952981L (pt) |
| NZ (1) | NZ261115A (pt) |
| WO (1) | WO1994016733A1 (pt) |
| ZA (1) | ZA94572B (pt) |
Families Citing this family (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5646131A (en) * | 1994-02-22 | 1997-07-08 | The Arab Company For Drug Industries And Medical Applicances (Acdima) | Method for solubilizing drugs using cyclodextrins and carboxylic acids |
| AUPM456894A0 (en) * | 1994-03-18 | 1994-04-14 | Glyzinc Pharmaceuticals Limited | Treatment for gastric disorders |
| IT1269578B (it) * | 1994-04-22 | 1997-04-08 | Chiesi Farma Spa | Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo acido, una ciclodestrina e una base. |
| US5750147A (en) * | 1995-06-07 | 1998-05-12 | Emisphere Technologies, Inc. | Method of solubilizing and encapsulating itraconazole |
| UA57734C2 (uk) | 1996-05-07 | 2003-07-15 | Пфайзер Інк. | Комплекси включення арилгетероциклічних солей |
| WO1998002186A1 (en) | 1996-07-11 | 1998-01-22 | Farmarc Nederland B.V. | Inclusion complex containing indole selective serotonin agonist |
| GB9711643D0 (en) * | 1997-06-05 | 1997-07-30 | Janssen Pharmaceutica Nv | Glass thermoplastic systems |
| KR19990001564A (ko) * | 1997-06-16 | 1999-01-15 | 유충식 | 용해도를 개선한 아졸계 항진균제 및 이를 함유하는 제제 |
| ES2174388T3 (es) * | 1997-06-27 | 2002-11-01 | Akzo Nobel Nv | Solucion liquida de medicamento para administracion oral. |
| US6077871A (en) * | 1997-11-26 | 2000-06-20 | Pfizer Inc. | Droloxifene pharmaceutical compositions |
| DK172860B1 (da) * | 1998-03-25 | 1999-08-16 | Pharmacosmos Holding As | Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman |
| JP2000080123A (ja) * | 1998-09-03 | 2000-03-21 | Toagosei Co Ltd | シアノアクリレート用硬化促進剤 |
| GB9822170D0 (en) * | 1998-10-13 | 1998-12-02 | Danbioyst Uk Ltd | Novel formulations of fexofenadine |
| FI982733A (fi) * | 1998-12-17 | 2000-06-18 | Orion Yhtymae Oyj | Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia |
| FI109332B (fi) | 1998-12-17 | 2002-07-15 | Orion Yhtymae Oyj | Toremifeenin liukoisia koostumuksia |
| US6740639B1 (en) * | 2000-03-29 | 2004-05-25 | Council Of Scientific & Industrial Research | Inclusion complees of a high potent opioid peptide, pharmaceutical compositions and method of treatment |
| GB0015239D0 (en) * | 2000-06-21 | 2000-08-16 | Biochemie Gmbh | Organic compounds |
| US6663897B2 (en) | 2001-02-06 | 2003-12-16 | Dsm Ip Assets B.V. | Oral itraconazole formulations and methods of making the same |
| JP2003063965A (ja) * | 2001-06-13 | 2003-03-05 | Otsuka Pharmaceut Factory Inc | 注射用シロスタゾール水性製剤 |
| WO2003052117A2 (en) * | 2001-09-19 | 2003-06-26 | Massachusetts Institute Of Technology | Methods and products related to non-viral transfection |
| US7446107B2 (en) | 2002-02-15 | 2008-11-04 | Transform Pharmaceuticals, Inc. | Crystalline forms of conazoles and methods of making and using the same |
| US7790905B2 (en) | 2002-02-15 | 2010-09-07 | Mcneil-Ppc, Inc. | Pharmaceutical propylene glycol solvate compositions |
| US7927613B2 (en) | 2002-02-15 | 2011-04-19 | University Of South Florida | Pharmaceutical co-crystal compositions |
| US20050025791A1 (en) | 2002-06-21 | 2005-02-03 | Julius Remenar | Pharmaceutical compositions with improved dissolution |
| JP4906233B2 (ja) | 2002-03-01 | 2012-03-28 | ユニバーシティー オブ サウス フロリダ | 少なくとも１種の有効薬剤成分を含有する多構成要素固相 |
| AU2003243354A1 (en) * | 2002-05-31 | 2003-12-19 | Transform Pharmaceuticals, Inc. | Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods |
| SI1542668T1 (sl) | 2002-08-20 | 2009-08-31 | Bristol Myers Squibb Co | Aripiprazol sestavljena formulacija in postopek |
| US7648678B2 (en) | 2002-12-20 | 2010-01-19 | Dako Denmark A/S | Method and system for pretreatment of tissue slides |
| US8183290B2 (en) | 2002-12-30 | 2012-05-22 | Mcneil-Ppc, Inc. | Pharmaceutically acceptable propylene glycol solvate of naproxen |
| US20050085446A1 (en) * | 2003-04-14 | 2005-04-21 | Babu M.K. M. | Fluoroquinolone formulations and methods of making and using the same |
| US7157446B2 (en) * | 2003-05-02 | 2007-01-02 | Bristol Myers Squibb Company | Complex of ras-farnesyltransferase inhibitor, a cyclodextrin, and ethanol |
| CN1515260B (zh) * | 2003-06-26 | 2010-05-05 | 沈阳药科大学 | 含hpcd的桂利嗪粉针剂和其固体制剂及其制备方法 |
| JP4870569B2 (ja) | 2003-11-13 | 2012-02-08 | ハンミ ホールディングス カンパニー リミテッド | 免疫グロブリン断片を用いた蛋白質結合体およびその製造方法 |
| US20070020299A1 (en) | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
| EP1570862A1 (en) * | 2004-02-25 | 2005-09-07 | JPM - The Jordanian Pharmaceutical Manufacturing Co. Ltd. | Highly soluble binary cyclodextrin inclusion complexes |
| JP2007525502A (ja) * | 2004-02-26 | 2007-09-06 | トランスフオーム・フアーマシユーチカルズ・インコーポレーテツド | コナゾール類の新規な結晶形態並びにそれらの製造および使用方法 |
| CN1997372B (zh) * | 2004-06-24 | 2010-06-02 | 西梯茜生命工学股份有限公司 | 包含依他康那唑的固态分散剂的制造方法及其医药组成物 |
| WO2006052922A2 (en) * | 2004-11-08 | 2006-05-18 | Eastman Chemical Company | Pharmaceutical formulations of cyclodextrins and selective estrogen receptor modulator compounds |
| WO2006052921A2 (en) * | 2004-11-08 | 2006-05-18 | Eastman Chemical Company | Cyclodextrin solubilizers for liquid and semi-solid formulations |
| DE102005041860A1 (de) * | 2005-09-02 | 2007-03-08 | Schering Ag | Nanopartikulärer Einschluss- und Ladungskomplex für pharmazeutische Formulierungen |
| WO2007047253A2 (en) * | 2005-10-11 | 2007-04-26 | Eastman Chemical Company | Pharmaceutical formulations of cyclodextrins and antifungal azole compounds |
| CN101990542A (zh) * | 2008-02-08 | 2011-03-23 | 德克萨斯大学董事会 | 环巴胺酒石酸盐及其用途 |
| CN101314045B (zh) * | 2008-05-09 | 2013-01-23 | 沈阳药科大学 | 桂利嗪的磺丁基醚-β-环糊精包合物及其制剂和制备方法 |
| NZ590489A (en) | 2008-07-03 | 2013-01-25 | Univ Virginia Patent Found | Unit dosage of apadenoson |
| EP2331092B1 (en) | 2008-08-21 | 2014-03-19 | The Johns Hopkins University | Methods and compositions for administration of 3-halopyruvate and related compounds for the treatment of cancer |
| US11020363B2 (en) | 2009-05-29 | 2021-06-01 | Cydex Pharmaceuticals, Inc. | Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same |
| MX357677B (es) | 2009-05-29 | 2018-07-19 | Cydex Pharmaceuticals Inc | Composiciones inyectables de melfalán que comprenden un derivado de ciclodextrina y métodos de fabricación y uso de las mismas. |
| JP5803150B2 (ja) * | 2011-03-02 | 2015-11-04 | 三菱瓦斯化学株式会社 | ピロロキノリンキノンーシクロデキストリン包接体 |
| ES2777939T3 (es) | 2013-09-09 | 2020-08-06 | Canimguide Therapeutics Ab | Moduladores del sistema inmunitario |
| CA2936940C (en) * | 2014-01-14 | 2023-07-04 | The Johns Hopkins University | Cyclodextrin compositions encapsulating a selective atp inhibitor and uses thereof |
| US9896614B2 (en) | 2014-11-05 | 2018-02-20 | Halliburton Energy Services, Inc. | Delayed acid breaker systems for filtercakes |
| AU2016229309B2 (en) | 2015-03-06 | 2021-12-02 | Canimguide Therapeutics Ab | Immune system modulators and compositions |
| CN106539752B (zh) * | 2015-09-18 | 2019-10-29 | 成都康弘药业集团股份有限公司 | 一种含有阿立哌唑的口服溶液及其制备方法 |
| WO2017079563A1 (en) | 2015-11-06 | 2017-05-11 | The Johns Hopkins University | Methods of treating liver fibrosis by administering 3-bromopyruvate |
| WO2021250482A1 (en) | 2020-06-11 | 2021-12-16 | Sentiss Pharma Private Limited | Ophthalmic compositions comprising a combination of fluoroquinolone antibacterial agent and an anti-inflammatory agent |
| KR102356618B1 (ko) * | 2021-11-17 | 2022-02-08 | 명지대학교 산학협력단 | 신규 포접복합체 및 이의 용도 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU182217B (en) * | 1980-10-17 | 1983-12-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing inclusive complexes of cyclodextrines and strong inorganic oxyacids |
| JPS60185772A (ja) * | 1984-03-05 | 1985-09-21 | Mitsui Pharmaceut Inc | 安定なカルモフ−ル−β−シクロデキストリンの包接化合物 |
| US5091171B2 (en) * | 1986-12-23 | 1997-07-15 | Tristrata Inc | Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use |
| JP2571199B2 (ja) * | 1987-11-25 | 1997-01-16 | 塩水港精糖株式会社 | 溶解性の高いサイクロデキストリンの製造方法 |
| US5646131A (en) * | 1994-02-22 | 1997-07-08 | The Arab Company For Drug Industries And Medical Applicances (Acdima) | Method for solubilizing drugs using cyclodextrins and carboxylic acids |
-
1993
- 1993-01-29 IT ITMI930141A patent/IT1263831B/it active IP Right Grant
-
1994
- 1994-01-26 KR KR1019950702913A patent/KR960700074A/ko active IP Right Grant
- 1994-01-26 AT AT94905707T patent/ATE228013T1/de not_active IP Right Cessation
- 1994-01-26 BR BR9406779A patent/BR9406779A/pt not_active Application Discontinuation
- 1994-01-26 DE DE69431747T patent/DE69431747D1/de not_active Expired - Lifetime
- 1994-01-26 AU AU59710/94A patent/AU691115B2/en not_active Ceased
- 1994-01-26 NZ NZ261115A patent/NZ261115A/en unknown
- 1994-01-26 WO PCT/EP1994/000205 patent/WO1994016733A1/en active IP Right Grant
- 1994-01-26 JP JP6516681A patent/JPH08508711A/ja not_active Ceased
- 1994-01-26 CZ CZ951943A patent/CZ284606B6/cs not_active IP Right Cessation
- 1994-01-26 US US08/481,519 patent/US5855916A/en not_active Expired - Fee Related
- 1994-01-26 CA CA002154874A patent/CA2154874A1/en not_active Abandoned
- 1994-01-26 HU HU9502251A patent/HU218796B/hu not_active IP Right Cessation
- 1994-01-26 EP EP94905707A patent/EP0681481B1/en not_active Expired - Lifetime
- 1994-01-27 IL IL10846094A patent/IL108460A/en not_active IP Right Cessation
- 1994-01-27 ZA ZA94572A patent/ZA94572B/xx unknown
-
1995
- 1995-07-27 FI FI953590A patent/FI953590A/fi unknown
- 1995-07-27 NO NO952981A patent/NO952981L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA94572B (en) | 1994-09-13 |
| FI953590A (fi) | 1995-09-14 |
| KR960700074A (ko) | 1996-01-19 |
| IL108460A0 (en) | 1994-04-12 |
| BR9406779A (pt) | 1996-02-06 |
| DE69431747D1 (de) | 2003-01-02 |
| WO1994016733A1 (en) | 1994-08-04 |
| HU218796B (hu) | 2000-12-28 |
| AU691115B2 (en) | 1998-05-07 |
| US5855916A (en) | 1999-01-05 |
| NO952981D0 (no) | 1995-07-27 |
| HUT72500A (en) | 1996-05-28 |
| ITMI930141A0 (it) | 1993-01-29 |
| ITMI930141A1 (it) | 1994-07-30 |
| CZ284606B6 (cs) | 1999-01-13 |
| FI953590A0 (fi) | 1995-07-27 |
| CZ194395A3 (en) | 1996-01-17 |
| JPH08508711A (ja) | 1996-09-17 |
| IT1263831B (it) | 1996-09-04 |
| ATE228013T1 (de) | 2002-12-15 |
| NZ261115A (en) | 1996-11-26 |
| AU5971094A (en) | 1994-08-15 |
| EP0681481B1 (en) | 2002-11-20 |
| EP0681481A1 (en) | 1995-11-15 |
| CA2154874A1 (en) | 1994-08-04 |
| NO952981L (no) | 1995-07-27 |
| HU9502251D0 (en) | 1995-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0681481B1 (en) | Highly soluble multicomponent inclusion complexes containing a base type drug, an acid and a cyclodextrin | |
| Jansook et al. | Cyclodextrins: Structure, physicochemical properties and pharmaceutical applications | |
| Loftsson et al. | Cyclodextrins as functional excipients: methods to enhance complexation efficiency | |
| Kurkov et al. | Cyclodextrins | |
| Albers et al. | Cyclodextrin derivatives in pharmaceutics | |
| JP3579060B2 (ja) | アリール―複素環式化合物塩の包接錯体 | |
| Messner et al. | Self-assembled cyclodextrin aggregates and nanoparticles | |
| Piel et al. | Development of a non-surfactant parenteral formulation of miconazole by the use of cyclodextrins | |
| US5773029A (en) | High solubility multicomponent inclusion complexes consisting of an acidic drug, a cyclodextrin and a base | |
| US6576261B1 (en) | Potentiation of inclusion complex formation of cyclodextrin derivatives | |
| US6077871A (en) | Droloxifene pharmaceutical compositions | |
| Smith et al. | Effect of SBE7-β-cyclodextrin complexation on carbamazepine release from sustained release beads | |
| KR20220123388A (ko) | 알킬화된 사이클로덱스트린 조성물 및 이의 제조 및 사용 방법 | |
| EP2529742B1 (en) | Pharmaceutical composition comprising dapagliflozin and cyclodextrin | |
| Pose-Vilarnovo et al. | Sulphamethizole-cyclodextrin-hydroxy propylmethyl cellulose multicomponent complexes | |
| Csabai et al. | Complexation of manidipine with cyclodextrins and their derivatives | |
| EP2943224B1 (en) | Voriconazole inclusion complexes | |
| US8716342B2 (en) | Method for preparing molecular complexes between adapalene and cyclodextrins | |
| Kulkarni et al. | Cyclodextrins and ternary complexes for solubility enhancement of poorly soluble drugs | |
| Charumanee et al. | Thermodynamic investigations on the inclusion complexation of piroxicam with cyclodextrin derivatives | |
| NO314438B1 (no) | Estramustin formuleringer med forbedrede farmasöytiske egenskaper, samt anvendelse derav | |
| JP2004531525A (ja) | アニリドとシクロデキストリンとの複合体、その製造および特に異常脂肪血症の治療のための医薬としてのその使用 | |
| US20040242538A1 (en) | Method to improve complexation efficacy and produce high-energy cylodextrincomplexes | |
| ITRE940045A1 (it) | Pannello isolante |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| FF | Patent granted | ||
| KB | Patent renewed | ||
| RH1 | Patent not in force |